REQUEST A DEMO
Total
USD $0.00
Search more companies

Boehringer Ingelheim Ilac Ticaret A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Boehringer Ingelheim Ilac Ticaret Anonim Sirketi Profile Updated: October 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Boehringer Ingelheim Ilac Ticaret Anonim Sirketi is a leading research-driven pharmaceutical company located in Istanbul. Since its establishment in 1885, the company has maintained its family business identity and focuses on long-term sustainable approaches. With over 53,000 employees, Boehringer Ingelheim serves more than 130 markets in three business areas: Human Health, Animal Health, and Contract Biopharmaceutical Production. The company's goal is to create value through innovation every day, aiming to improve the lives of people and animals alike.

Headquarters
Nidakule Levent Apartmani No:7-9-15 Esentepe Mahallesi Harman 1 Sokak Sisli
Istanbul; Marmara; Postal Code: 34394

Contact Details: Purchase the Boehringer Ingelheim Ilac Ticaret A.S. report to view the information.

Website: http://www.boehringer-ingelheim.com.tr

Basic Information
Total Employees:
Purchase the Boehringer Ingelheim Ilac Ticaret A.S. report to view the information.
Outstanding Shares:
Purchase the Boehringer Ingelheim Ilac Ticaret A.S. report to view the information.
Incorporation Date:
July 13, 1994
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Boehringer Ingelheim Ilac Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
94.48%
Total operating revenue
94.48%
Operating profit (EBIT)
-7.35%
Net Profit (Loss) for the Period
38.75%
Total assets
62.33%
Total equity
49.96%
Operating Profit Margin (ROS)
-9.31%
Net Profit Margin
-0.7%
Return on Equity (ROE)
-2.26%
Debt to Equity Ratio
6.27%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?